Avilex Pharma
PrivateLast Round
Grant
Dec 1, 2018
Total Funding Raised
$10.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avilex Pharma is a biotechnology company that develops neuroprotectants intended to treat acute neurological conditions such as ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avilex Pharma Comparables
Compare Avilex Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NoNO Inc. | 89% | |
| Astrocyte Pharmaceuticals Inc. | 82% | |
| aptaTargets | 81% |
Avilex Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2018 | ||||
| Grant | Jan 28, 2015 | ||||
| Seed | Apr 15, 2013 |
Avilex Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Novo Holdings | Grant, Seed |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 324% MoM.
- May 11, 2026
Monthly visitors grew 98% MoM, reaching 160.
Avilex Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avilex Pharma's valuation, stock price, and market status.
Is Avilex Pharma a public or private company?
Avilex Pharma is a private company.
What is the current stock price of Avilex Pharma?
Avilex Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Avilex Pharma worth (valuation)?
Valuation information for Avilex Pharma is not publicly available.
Can I buy Avilex Pharma stock?
Avilex Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avilex Pharma's last funding round?
Avilex Pharma's most recent funding round was Grant on December 1, 2018.
Who are the main investors in Avilex Pharma?
Key investors in Avilex Pharma include Innovation Fund Denmark, Novo Holdings.
Will Avilex Pharma IPO soon?
No public IPO plans have been announced for Avilex Pharma.
How can I track Avilex Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avilex Pharma's secondary market activity and sign up for updates.